Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058512
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.05K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+85$2.88+$244.8175,655Direct
Sep 2, 2021Common StockPPurchaseAcquired+85$2.88+$244.8175,740Direct
Sep 3, 2021Common StockPPurchaseAcquired+85$2.85+$242.25175,825Direct
Sep 7, 2021Common StockPPurchaseAcquired+85$2.79+$237.15175,910Direct
Sep 8, 2021Common StockPPurchaseAcquired+85$2.89+$245.65175,995Direct
Sep 9, 2021Common StockPPurchaseAcquired+85$2.77+$235.45176,080Direct
Sep 10, 2021Common StockPPurchaseAcquired+85$2.78+$236.3176,165Direct
Sep 13, 2021Common StockPPurchaseAcquired+85$2.96+$251.6176,250Direct
Sep 14, 2021Common StockPPurchaseAcquired+85$3.02+$256.7176,335Direct
Sep 15, 2021Common StockPPurchaseAcquired+85$2.86+$243.1176,420Direct
Sep 16, 2021Common StockPPurchaseAcquired+85$2.91+$247.35176,505Direct
Sep 17, 2021Common StockPPurchaseAcquired+85$2.85+$242.25176,590Direct
Sep 20, 2021Common StockPPurchaseAcquired+85$2.82+$239.7176,675Direct
Sep 21, 2021Common StockPPurchaseAcquired+85$2.81+$238.85176,760Direct
Sep 22, 2021Common StockPPurchaseAcquired+85$2.76+$234.6176,845Direct
Sep 23, 2021Common StockPPurchaseAcquired+85$2.75+$233.75176,930Direct
Sep 24, 2021Common StockPPurchaseAcquired+85$2.74+$232.9177,015Direct
Sep 27, 2021Common StockPPurchaseAcquired+85$2.79+$237.15177,100Direct
Sep 28, 2021Common StockPPurchaseAcquired+85$2.76+$234.6177,185Direct
Sep 29, 2021Common StockPPurchaseAcquired+85$2.82+$239.7177,270Direct
Sep 30, 2021Common StockPPurchaseAcquired+85$2.72+$231.2177,355Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)